image
Aligos Therapeutics, Inc. ALGS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 9.16
1.33 %
$ 56 M
Market Cap
-0.52
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
191.35%
EBIT Estimate
--17.61%
Net Income Estimate
23.66%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Aligos Therapeutics, Inc.
image
ALGS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart ALGS

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ALGS

image
$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ALGS

image
$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)202120212022202220232023202420242025202520262026202720272028202820292029